MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience Current Ratio 2011-2026 | VIVO
Annual Current Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 6.92 | 5.75 | 5.85 | 5.62 | 8.06 | 8.21 | 5.26 | 5.23 | 5.92 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.21 | 5.23 | 6.31 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
RadNet
RDNT
|
1.56 | $ 56.78 | -4.44 % | $ 4.27 B |  USA |
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Soleno Therapeutics
SLNO
|
4.96 | $ 30.52 | -4.12 % | $ 1.55 B | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Neuronetics
STIM
|
1.23 | $ 1.4 | 4.89 % | $ 92.3 M | USA |
 |
Sotera Health Company
SHC
|
1.23 | $ 13.26 | -2.1 % | $ 3.77 B | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
|
Biodesix
BDSX
|
1.27 | $ 14.18 | -2.91 % | $ 1.84 B | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
2.52 | $ 1.16 | 0.87 % | $ 6.32 M | USA |
 |
Trinity Biotech plc
TRIB
|
0.746 | $ 0.6 | -2.18 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
3.8 | - | - | $ 2.68 B | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
7.05 | $ 23.99 | -2.87 % | $ 666 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 158.77 | -3.85 % | $ 7.87 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 195.86 | -1.16 % | $ 21.7 B | USA |
 |
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
4.85 | $ 8.45 | - | $ 33.7 M | Israel |
 |
Waters Corporation
WAT
|
2.02 | $ 290.62 | -3.31 % | $ 17.3 B | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
0.87 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
IQVIA Holdings
IQV
|
1.28 | $ 164.81 | -2.71 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
2.51 | $ 8.79 | -3.93 % | $ 1.91 B | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Personalis
PSNL
|
4.02 | $ 6.41 | -12.43 % | $ 380 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 266.15 | -0.83 % | $ 22.1 B | USA |
 |
Senseonics Holdings
SENS
|
1.94 | $ 6.45 | -1.68 % | $ 269 M | USA |
 |
Psychemedics Corporation
PMD
|
2.18 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
4.93 | $ 25.64 | -5.75 % | $ 33.3 M | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 16.82 | -3.72 % | $ 896 M | USA |
 |
Quotient Limited
QTNT
|
0.861 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
1.71 | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
0.504 | - | 5.66 % | $ 22.7 M | Britain |
 |
VolitionRx Limited
VNRX
|
0.265 | $ 0.2 | 1.08 % | $ 19.2 M |  Singapore |